Use of Amino Terminal Type III Procollagen Peptide (P3NP) Assay in Methotrexate Therapy for Psoriasis

Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.2005.041533
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Clinical and Echocardiographic Correlates of Plasma Procollagen Type III Amino-Terminal Peptide Levels in the Community

American Heart Journal
Cardiovascular MedicineCardiology
2007English

Enzyme-Linked Immunosorbent Assay for Serum Procollagen Type III Peptide in Rats With Hepatic Fibrosis.

Journal of Veterinary Medical Science
Veterinary
1998English

Serum Type I and Type III Procollagen Peptide Levels in Sarcoidosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1996English

Relation Between Plasma Amino-Terminal Propeptide of Procollagen Type III and Left Ventricular Longitudinal Strain in Essential Hypertension

Heart
Cardiovascular MedicineCardiology
2005English

Serum Type III Procollagen Peptide in Asbestos Workers: An Early Indicator of Pulmonary Fibrosis

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
1989English

Amino Terminal Pro-B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2006English

Serum Enzymes of Collagen Synthesis and Type III Procollagen Amino-Propeptide in Nigerian Patients With Sickle Cell Disease

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1986English

Methotrexate Hepatotoxicity in Psoriasis.

BMJ
1972English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy